Indian Immunologicals Limited (IIL), a leading vaccine manufacturer, has partnered with the Central Institute of Freshwater Aquaculture (CIFA) to develop a vaccine against Hemorrhagic Septicemia in freshwater fish. This infection, caused by the opportunistic pathogenic bacterium Aeromonas hydrophila, is a significant economic problem in Indian aquaculture. All of the cultured freshwater fish species in India are susceptible to this disease.
The aquaculture sector is crucial to India’s economy, with the fisheries sector providing a livelihood for approximately 28 million people. India is the world’s third-largest fish producer, with over 65% of the country’s fish produced through inland fisheries and aquaculture. Disease is a major constraint to the aquaculture industry, with an estimated 20% of all cultured aquatic animals lost due to infectious diseases, resulting in approximately $10 billion in losses annually on a global scale. Vaccination is seen as the most promising and environmentally safe method for controlling these diseases.